Accretion Pharmaceuticals Limited (NSE:ACCPL)
India flag India · Delayed Price · Currency is INR
202.50
-9.50 (-4.48%)
At close: Nov 6, 2026

Accretion Pharmaceuticals Cash Flow Statement

Millions INR. Fiscal year is Apr - Mar.

Operating Activities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Net Income
131.1796.6867.9414.931.040.79
Depreciation & Amortization
16.8612.117.752.249.238.1
Other Operating Activities
12.5110.1216.316.910.7610.35
Change in Accounts Receivable
-101.28-107.39-58.57-70.47-17.3112.55
Change in Inventory
-71.54-77.65-61.34-144.76-8.31-19.75
Change in Accounts Payable
19.36-18.2110.0966.0811.125.71
Change in Other Net Operating Assets
-27.77-61.0111.65--3.323.74
Operating Cash Flow
-20.7-145.34-6.19-115.093.2121.5
Operating Cash Flow Growth
-----85.06%-

Investing Activities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Capital Expenditures
-80.98-85.34-16.11-54.78-11.78-2.57
Sale of Property, Plant & Equipment
----0.79-
Investing Cash Flow
-68.38-85.34-16.11-54.78-11-2.57

Financing Activities

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Short-Term Debt Issued
--63.69---
Long-Term Debt Issued
---134.788.58-
Total Debt Issued
44.27-63.69134.788.58-
Short-Term Debt Repaid
--14.77----
Long-Term Debt Repaid
--3.05-57.43---2.81
Total Debt Repaid
44.55-17.82-57.43---2.81
Net Debt Issued (Repaid)
88.81-17.826.26134.788.58-2.81
Issuance of Common Stock
32.15297.5530406.59-
Repurchase of Common Stock
------2.87
Other Financing Activities
-12.17-9.34-14.37-3.99-10.76-10.17
Financing Cash Flow
108.79270.3821.89170.794.4-15.85

Net Cash Flow

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Miscellaneous Cash Flow Adjustments
--0----0
Net Cash Flow
19.7139.7-0.410.92-3.383.08

Free Cash Flow

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Free Cash Flow
-101.68-230.68-22.3-169.87-8.5718.93
Free Cash Flow Growth
------
Free Cash Flow Margin
-10.07%-25.74%-3.89%-127.22%-2.90%8.38%
Free Cash Flow Per Share
-9.15-21.55-2.78-22.35--
Levered Free Cash Flow
-103.46-230.22-44.15-111.16-19.15-
Unlevered Free Cash Flow
-97.07-225.6-35.48-109.56-12.74-

Additional Metrics

Fiscal Year
TTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Sep '26 Mar '26 Mar '25 Mar '24 Mar '23 Mar '22
Cash Interest Paid
5.649.3414.373.9910.7610.17
Cash Income Tax Paid
17.2433.3827.77-7.890.350.07
Change in Working Capital
-181.24-264.25-98.17-149.15-17.822.26